Neil McFarlane
Chief Executive Officer at ZEVRA THERAPEUTICS, INC.
Net worth: 380 125 $ as of 2024-03-30
Profile
Mr. Neil F.
McFarlane is a President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. and an Independent Director at Collegium Pharmaceutical, Inc. He is on the Board of Directors at Zevra Therapeutics, Inc. and Collegium Pharmaceutical, Inc. Mr. McFarlane was previously employed as a Chief Executive Officer by Adamas Pharmaceuticals LLC, a Chief Operating Officer by Travere Therapeutics, Inc., a Vice President by UCB, Inc., and a Chief Executive Officer & Director by Adamas Pharmaceuticals, Inc. He received his undergraduate degree from the University of Florida and a graduate degree from the University of Florida.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-26 | 9,792 ( 0.03% ) | 380 125 $ | 2024-03-30 |
Neil McFarlane active positions
| Companies | Position | Start |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2022-04-05 |
| ZEVRA THERAPEUTICS, INC. | Chief Executive Officer | 2023-10-09 |
Former positions of Neil McFarlane
| Companies | Position | End |
|---|---|---|
| Adamas Pharmaceuticals, Inc. | Chief Executive Officer | 2021-10-31 |
| ADAMAS PHARMACEUTICALS, INC. | Chief Executive Officer | 2020-12-31 |
| TRAVERE THERAPEUTICS, INC. | Chief Operating Officer | 2019-05-30 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Corporate Officer/Principal | 2015-12-31 |
Training of Neil McFarlane
| University of Florida | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
| Adamas Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Neil McFarlane
